Finance entity

Cushman & Wakefield

Company CWK

markets is the sole category represented across all 1 tracked stories. Cushman & Wakefield is most often covered alongside European Life Sciences Coalition, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 4.7 across the same-window beat baseline.

Last mentioned: Feb 18, 2026

Entity pulse

Recent coverage · Cushman & Wakefield

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Cushman & Wakefield

markets is the sole category represented across all 1 tracked stories. Cushman & Wakefield is most often covered alongside European Life Sciences Coalition, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 4.7 across the same-window beat baseline. At 7, the average consequence score sits above the same-window beat average of 6.7. Cushman & Wakefield appears in 1 tracked Finance story from February 18, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 90 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Cushman & Wakefield. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Cushman & Wakefield 1

Markets Bearish

European VCs Form Coalition to Bridge Life Sciences Funding Gap

Leading European venture capital firms have launched the European Life Sciences Coalition to address a systemic funding crisis and prevent the migration of high-growth biotech firms to U.S. markets. The initiative seeks to unlock institutional capital and harmonize regulations to bridge the late-stage investment gap between Europe and North America.

3 sources

Source: BioXconomy · Cushman & Wakefield

Cushman & Wakefield is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.